22.418 makale bulundu

Beyin nöromodülasyonu için uydu terapisi dağıtım sistemi

Satellite therapy delivery system for brain neuromodulation

STEVENSON ROBERT A, FRYSZ CHRISTINE, MUFFALETTO BARRY, SIEGLER ROBERT W, WINN STEVEN W, SKWARA THOMAS A, FRUSTACI DOMINICK J.

· 2009-11-18

BEYİN NEUROMODULASYONU İÇİN SATELİTE TERAPİ TESLİM SİSTEMİ

SATELLITE THERAPY DELIVERY SYSTEM FOR BRAIN NEUROMODULATION

STEVENSON ROBERT A, FRYSZ CHRISTINE A, MUFFOLETTO BARRY C, SIEGLER ROBERT W, WINN STEVEN W, SKWARA THOMAS A, FRUSTACI DOMINICK J.

· 2009-11-16

AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DIŞI, ÇOKLU SCLEROSİS VE VİRAL BAZLI KANSERLER İÇİN İŞLEMLER

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

NELSON GEORGE.

· 2009-11-12

Pimavanserin, parkinson hastalığı psikozunun tedavisi için bir serotonin(2A) reseptör ters agonisti.

Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.

Meltzer HY, Mills R, Revell S, Williams H, Johnson A, Bahr D, Friedman JH.

Neuropsychopharmacology · 2009-11-11

DOI: 10.1038/npp.2009.176PMID: 19907417

Rotenon kaynaklı kronik Parkinson modelinde laktoferrin modifiye edilmiş nanopartiküller kullanılarak gen terapisi.

Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model.

Huang R, Ke W, Liu Y, Wu D, Feng L, Jiang C, Pei Y.

J Neurol Sci · 2009-11-11

DOI: 10.1016/j.jns.2009.09.032PMID: 19909981

NEURODEGENERATİF HASTALIK VE yıpranmaların TEDAVİ VE ÖNLEM YÖNTEMLERİ.

METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS.

SHI YI, NAGELE ROBERT.

· 2009-11-10

Parkinson hastalığında nöroinflamasyon: nöronal ölümdeki rolü ve terapötik müdahale için etkileri.

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

Tansey MG, Goldberg MS.

Neurobiol Dis · 2009-11-10

DOI: 10.1016/j.nbd.2009.11.004PMID: 19913097

NOVEL, ALZHEIMER'İN HASTALIK VE PARKINSON'UN HASTALIKLARINA KARŞI KORUNMA VE TERAPİ İÇİN BDNF EXpression ve FARMACEUTICAL KOMPZSİYONU ÜZERİNE UPREGULATING

NOVEL PEPTIDES UPREGULATING BDNF EXPRESSION AND PHARMACEUTICAL COMPOSITION FOR PROTECTION AND THERAPY AGAINST ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE COMPRISING THE SAME

KIM KIL LYONG, KIM HONG GI, JUNG WOO RAM, PARK DONG IK, SHIN MIN KYOO.

· 2009-11-06

POLİELEKTROLİTELERLE KAPLANMIŞ GOLD NANOP MAKALELERİ VE NEURODEGENERATİF HASTALIKLARININ PROTEIN AGGREGATELERDEN ALINMASI İÇİN MEDYA KULLANIMI

GOLD NANOPARTICLES COATED WITH POLYELECTROLYTES AND USE THEREOF AS MEDICAMENT FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES CAUSED BY PROTEIN AGGREGATES

LEGNAME GIUSEPPE ANTONIO, KROL SILKE, COSTA DE SOUSA MARIA FERNANDA.

· 2009-11-05

Parkinson hastalığının tedavisinde Levodopa/karbidopa ve entakapon: etkinlik, güvenlik ve hasta tercihi.

Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference.

Müller T.

Patient Prefer Adherence · 2009-11-03

DOI: 10.2147/ppa.s4084PMID: 19936145

Parkinson hastalığı olan hastalarda merkezi levodopa akını ve levodopaya klinik motor yanıt motor dalgalanmalar ve diskinezilerle karmaşık.

Central levodopa influx and the clinical motor response to levodopa in patients with Parkinson disease complicated with motor fluctuations and dyskinesias.

López-Ariztegui N, Arévalo MA, de Ceballos ML, Grandas F.

Clin Neuropharmacol · 2009-11-01

DOI: 10.1097/wnf.0b013e3181b40378PMID: 19667975

Prion hastalığının tedavisi için RNAi: nörodejenerasyona müdahale için bir pencere?

RNAi for the treatment of prion disease: a window for intervention in neurodegeneration?

White MD, Mallucci GR.

CNS Neurol Disord Drug Targets · 2009-11-01

DOI: 10.2174/187152709789541934PMID: 19702576